Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA.
Department of Medicine, Samaritan Medical Center, Watertown, New York, USA.
Clin Endocrinol (Oxf). 2021 Aug;95(2):269-276. doi: 10.1111/cen.14500. Epub 2021 Jun 3.
The aim of this study was to describe rates and characteristics of non-elective 30-day readmission among patients hospitalized for adrenal insufficiency and to assess predictors of readmission.
We analysed the 2018 National Readmission Database. Adrenal insufficiency hospitalizations were identified using the International Classification of Diseases, Tenth Revisions, Clinical Modification diagnosis codes for principal diagnostic codes of primary adrenal insufficiency, Addisonian crisis, drug-induced adrenocortical insufficiency, and other and unspecified adrenocortical insufficiency.
During the study period, 7738 index hospitalizations were identified as patients with AI who met the inclusion criteria. Of these, 7691 were discharged alive.
We utilized chi-squared tests to compare baseline characteristics between readmissions and index hospitalizations. Multivariate Cox regression was used to identify independent predictors of readmission.
The 30-day all-cause readmission rate for AI was 17.3%. About 1 in 5 readmissions was for AI. Other reasons for readmission included sepsis (10.8%), unspecified pneumonia (3.1%) and acute renal failure unspecified (1.6%). Readmission was associated with significantly higher odds of inpatient mortality. Independent predictors of 30-day all-cause readmissions included index hospitalizations with the Charlson Comorbidity Index (CCI) ≥3 (adjusted hazards ratio (aHR): 2.53, 95% CI: 1.85-3.46, p < .001), protein-energy malnutrition (aHR: 1.28, 95% CI: 1.02-1.60, p = .035) and obesity (aHR: 1.26, 95% CI: 1.02-1.56, p = .035).
The 30-day all-cause readmission rate was 17.3%. AI was the most common reason for readmission among other causes. Readmissions were associated with increased mortality. CCIs of 3 or more, protein-energy malnutrition and obesity were significant predictors of readmission.
本研究旨在描述肾上腺功能减退患者非选择性 30 天再入院率的情况,并评估再入院的预测因素。
我们分析了 2018 年国家再入院数据库。使用国际疾病分类第十次修订版临床修正诊断代码,将肾上腺功能减退症住院患者的主要诊断代码为主诊断代码,确定为原发性肾上腺功能减退症、阿狄森氏危象、药物诱导的肾上腺皮质功能不全和其他和未特指的肾上腺皮质功能不全。
在研究期间,确定了 7738 例符合纳入标准的 AI 指数住院患者。其中 7691 例出院时存活。
我们使用卡方检验比较再入院和指数住院之间的基线特征。多变量 Cox 回归用于确定再入院的独立预测因素。
AI 的 30 天全因再入院率为 17.3%。约五分之一的再入院是由于 AI。其他再入院原因包括败血症(10.8%)、未特指肺炎(3.1%)和未特指急性肾衰竭(1.6%)。再入院与更高的住院死亡率显著相关。30 天全因再入院的独立预测因素包括 Charlson 合并症指数(CCI)≥3 的指数住院(调整后的危险比(aHR):2.53,95%CI:1.85-3.46,p<0.001)、蛋白质-能量营养不良(aHR:1.28,95%CI:1.02-1.60,p=0.035)和肥胖症(aHR:1.26,95%CI:1.02-1.56,p=0.035)。
30 天全因再入院率为 17.3%。在其他原因中,AI 是再入院的最常见原因。再入院与死亡率增加有关。CCI 为 3 或更高、蛋白质-能量营养不良和肥胖症是再入院的显著预测因素。